Handelsbanken Fonder AB quarter change: Foreign ADRs, Added
In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), from the quarter ended 2026-03-31 to 2026-06-30, Handelsbanken Fonder AB opened 0 positions, added to 0, reduced 0, sold out of 1 and left 0 unchanged. The largest increase in value was ASCENDIS PHARMA A/S SPONSORED ADR (-$3,538); the largest decrease was ASCENDIS PHARMA A/S SPONSORED ADR (-$3,538).
Two Form 13F-HR filings compared (SEC CIK 1398318): 2026-03-31 (filed 2026-04-28) and 2026-06-30 (filed 2026-07-10). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
No position of this class changed this way between the two filings.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| PROTECTIVE LIFE CORP | United States | $0.030B | 155 |
| Veltria Advisors Corp. | United States | $0.030B | 38 |
| IDG-Accel China Capital GP II Associates Ltd. | Hong Kong | $0.030B | 1 |
| Lykos Global Management, LP | United States | $0.030B | 3 |
| AJU IB Investment Co., Ltd. | South Korea | $0.031B | 6 |
| LORD, ABBETT & CO. LLC | United States | $0.031B | 557 |
| One68 Global Capital, LLC | United States | $0.031B | 40 |
| Crescent Park Management, L.P. | United States | $0.029B | 7 |
| Laidlaw Wealth Management LLC | United States | $0.029B | 49 |
| Worth Venture Partners, LLC | United States | $0.032B | 55 |